Medical News Feed
German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | H2 -antagonists (H2 -receptor antagonists / H 2 -blockers). |
| Generic Name : | Ranitidine hydrochloride |
| Drug description : | Zantac Tablets: 150mg white five- sided f-c tablets; 300mg white f-c tablets. Both marked with tablet name, strength and GLAXO. Zantac Syrup: sugar-free syrup. Zantac Injection: solution in ampoules. Zantac Effervescent: white effervescent tablets. |
| Presentation : | Zantac Tablets: Ranitidine (as hydrochloride) 150mg , 300mg . Zantac Syrup: Ranitidine (as hydrochloride) 150mg per 10mL, ethanol 7.5%. Zantac Injection: Ranitidine (as hydrochloride) 50mg per 2mL. Zantac Effervescent: Ranitidine (as hydrochloride) 150mg , 300mg . |
| Indications : | Treatment of duodenal, benign gastric and post-operative ulceration, including that due to NSAIDs. Prevention of NSAID induced duodenal ulcers. Duodenal ulcers associated with Helicobacter pylori . Oesophageal reflux, reduction of gastric acid, chronic episodic dyspepsia. Moderate to severe oesophagitis. Zollinger-Ellison syndrome. Prophylaxis of haemorrhage in stress ulcer or bleeding peptic ulcer. Prophylaxis of acid aspiration during general anaesthesia. |
| Adult Dosage : | Duodenal and gastric ulcer, 150 mg twice daily or 300 mg at bedtime for four weeks or 300 mg twice daily; maintenance, 150 mg at bedtime. DU with H. pylori , 300 mg at bedtime or 150 mg twice daily for four weeks plus amoxicillin 750 mg three times daily and metronidazole 500 mg three times daily for first 2 weeks. Prevention of NSAID induced duodenal ulcer, 150 mg twice daily. Reflux oesophagitis, 150 mg twice daily or 300 mg at bedtime for up to 12 weeks. If moderate to severe, 150 mg four times daily for up to 12 weeks. Long term treatment of healed oesophagitis, 150 mg twice daily. Zollinger-Ellison syndrome, 150 mg three times daily. Increase to 6 g daily if necessary. Chronic episodic dyspepsia, 150 mg twice daily for up to 6 weeks. Prophylaxis of haemorrhage, 150 mg twice daily substituted for inj. once oral feeding commences. |
| Child Dosage : | Under 2 years, not recommended; over 2 years, peptic ulceration only, 2 - 4 mg/kg twice daily; maximum 300 mg daily. Exclude malignant disease before treatment. Impaired renal function. Pregnancy. Lactation. |
| Adverse Reactions : | Headache, dizziness. Rarely hepatitis, thrombocytopenia, leucopenia, hypersensitivity, confusion, breast symptoms. |
| Manufacturer : | GlaxoSmithKline(GSK) |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org